Delivery Order SPE2DB24D2205-SPE2DB24FDXLL
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $30,248.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET, with a performance period through September 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a wide range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,163.08 firm-fixed-price delivery order contract to Amerisource Bergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a period of performance through September 13, 2024. This contract award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Amerisource Bergen,...
The U.S. Defense Logistics Agency (DLA) awarded a $15,226.39 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565712258 RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the military and other government healthcare...
The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,733.44 firm fixed-price delivery order is for RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,742.57 firm fixed-price delivery order contract covers the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,419.49 firm fixed-price delivery order contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...